These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8954064)

  • 1. Development of acromegaly during treatment of hyperprolactinemia with bromocriptine: an unusual acidophil stem cell adenoma.
    Page MD; Bridges LR; Barth JH; McNichol AM; Belchetz PE
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4484-7. PubMed ID: 8954064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.
    Cremonini N; Graziano E; Chiarini V; Sforza A; Zampa GA
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1166-9. PubMed ID: 1400888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Space occupying growth of a pituitary adenoma producing hGH and hPrl during bromocriptin therapy.
    Halves E
    Clin Neurol Neurosurg; 1977; 80(4):251-7. PubMed ID: 216515
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
    Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS
    J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A; Landi ML; Cappabianca P; Di Salle F; Rossi FW; Pivonello R; Di Somma C; Faggiano A; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Twin pregnancy following bromocriptine in an acromegalic patient staying sterile after removal of a pituitary adenoma. Immunocytochemical study of the tumor (author's transl)].
    Brun JM; Bloch B; Bugnon C; Putelat R
    Ann Endocrinol (Paris); 1979; 40(6):551-2. PubMed ID: 232833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and therapeutic particularities of depression associated with pituitary adenoma].
    Ghanem A; Mouna A; Ben Nasr S; Ben Hadj AB
    Tunis Med; 2009 Aug; 87(8):547-8. PubMed ID: 20180366
    [No Abstract]   [Full Text] [Related]  

  • 8. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia.
    Ciccarelli E; Ghigo E; Mazza E; Andreis M; Massara F; Lancranjan I; Camanni F
    J Endocrinol Invest; 1987 Apr; 10(2):179-82. PubMed ID: 3584856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical acromegaly with undetectable growth hormone and hyperprolactinemia.
    Valenta LJ; Elias AN
    J Natl Med Assoc; 1987 May; 79(5):555, 559-60. PubMed ID: 3586051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine in the medical management of acromegaly.
    Besser GM; Wass JA; Thorner MO
    Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.
    Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T
    Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of acromegaly.
    Melmed S; Braunstein GD; Horvath E; Ezrin C; Kovacs K
    Endocr Rev; 1983; 4(3):271-90. PubMed ID: 6354702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological interpretation of the syndrome of acromegaly (acidophil adenoma of the hypophysis in adults) and of the syndrome of gigantism (acidophil adenoma of the hypophysis in adolescents).
    Hrbek V
    Acta Univ Palacki Olomuc Fac Med; 1976; 80():157-61. PubMed ID: 233703
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone response to oral glucose before and after transfrontal pituitary surgery and radiotherapy in acromegaly.
    Dash RJ; Saini JS; Chander S; Kak VK; Ayyagari S
    J Assoc Physicians India; 1986 Mar; 34(3):171-3. PubMed ID: 3015867
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of acromegaly in a patient with prolactinemia: a case study.
    Badawy SZ; Anderson GH; Shende MC; Marshall L
    Fertil Steril; 1984 Dec; 42(6):926-8. PubMed ID: 6094262
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride.
    Dallabonzana D; Liuzzi A; Oppizzi G; Cozzi R; Verde G; Chiodini P; Rainer E; Dorow R; Horowski R
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1002-7. PubMed ID: 3745401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.